Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions

被引:149
作者
So, Jae-Seon [1 ]
Kwon, Ho-Keun [1 ]
Lee, Choong-Gu [1 ]
Yi, Hwa-Jung [1 ]
Park, Jin-A. [1 ]
Lim, So-Yeon [2 ]
Hwang, Ki-Chul [2 ]
Jeon, Young Ho [3 ]
Im, Sin-Hyeog [1 ]
机构
[1] GIST, Dept Life Sci, Kwangju 500712, South Korea
[2] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Div Cardiol, Seoul 120752, South Korea
[3] KBSI, Bio Magnet Resonance Res Ctr, Chungbuk 363883, South Korea
关键词
rheumatoid arthritis; collagen-induced arthritis; Lactobacillus casei; probiotics; CD4(+) T cells; cytokines;
D O I
10.1016/j.molimm.2007.12.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Although the beneficial effects of probiotics on wide variety of diseases have been shown, little is known about how probiotics modulate the immune system. In this study we elucidated the underlying mechanisms how Lactobacillus casei (L. casei) protects against rheumatoid arthritis (RA) progression by investigating the effector functions of CD4(+) T cells. Oral administration of L. casei suppressed coil agen-induced arthritis (CIA) and reduced paw swelling, lymphocyte infiltration and destruction of cartilage tissue. L. casei administration reduced type II collagen (CII)-reactive proinflammatory molecules (IL-1 beta, IL-2, IL-6, IL-12, IL-17, IFN-gamma, TNF-alpha and Cox-2) by CD4(+) T cells. L. casei administration also reduced translocation of NF-kappa B into nucleus and CII-reactive Th1-type IgG isotypes IgG2a and IgG2b, while up-regulating immunoregulatory IL-10 levels. Our results suggest that oral administration of L casei suppresses the type II collagen-reactive effector function of Th1-type cellular and humoral immune responses in arthritic inflammation. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2690 / 2699
页数:10
相关论文
共 61 条
[1]
Arend WP, 2001, ARTHRIT RHEUM-ARTHR, V45, P101
[2]
Lactobacillus GG bacteria ameliorate arthritis, in Lewis rats [J].
Baharav, E ;
Mor, F ;
Halpern, M ;
Weinberger, A .
JOURNAL OF NUTRITION, 2004, 134 (08) :1964-1969
[3]
MECHANISM OF ACTION OF CYCLOSPORINE IN RHEUMATOID-ARTHRITIS [J].
BENTIN, J .
CLINICAL RHEUMATOLOGY, 1995, 14 :22-25
[4]
Bettelli E, 1998, J IMMUNOL, V161, P3299
[5]
Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse [J].
Calcinaro, F ;
Dionisi, S ;
Marinaro, M ;
Candeloro, P ;
Bonato, V ;
Marzotti, S ;
Corneli, RB ;
Ferretti, E ;
Gulino, A ;
Grasso, F ;
De Simone, C ;
Di Mario, U ;
Falorni, A ;
Boirivant, M ;
Dotta, F .
DIABETOLOGIA, 2005, 48 (08) :1565-1575
[6]
Constantin A, 1998, ARTHRITIS RHEUM, V41, P48, DOI 10.1002/1529-0131(199801)41:1<48::AID-ART7>3.3.CO
[7]
2-B
[8]
B-LYMPHOCYTES AND HUMORAL IMMUNE-RESPONSES IN RHEUMATOID-ARTHRITIS [J].
DECLERCK, LS .
CLINICAL RHEUMATOLOGY, 1995, 14 :14-18
[9]
THE ROLE OF T-CELLS IN RHEUMATOID-ARTHRITIS [J].
DEKEYSER, F ;
ELEWAUT, D ;
VERMEERSCH, J ;
DEWEVER, N ;
CUVELIER, C ;
VEYS, EM .
CLINICAL RHEUMATOLOGY, 1995, 14 :5-9
[10]
Molecular mechanisms of interleukin-10-mediated inhibition of NF-κB activity:: a role for p50 [J].
Driessler, F ;
Venstrom, K ;
Sabat, R ;
Asadullah, K ;
Schottelius, AJ .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 135 (01) :64-73